BioCardia (BCDA) Share-based Compensation (2010 - 2026)

BioCardia (BCDA) has reported Share-based Compensation for 16 consecutive years, with $502932.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 200.31% year-over-year to $502932.0 in Q2 2026; TTM through Jun 2026 was $502932.0, a 200.31% increase from a year earlier, with the FY2025 full-year figure at $628.0 billion, down 9.9% from the prior year.
• Share-based Compensation was $502932.0 for Q2 2026 at BioCardia, roughly flat from $505010.0 in the prior quarter.
• Over five years, Share-based Compensation peaked at $2.6 million in Q2 2023 and troughed at $85000.0 in Q4 2025.
• A 5-year average of $1.0 million and a median of $391466.0 in 2022 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation slumped 93.03% in 2025 and jumped 200.31% in 2026, its largest moves.
• Over 5 years, Share-based Compensation stood at $280000.0 in 2022, then sank by 34.29% to $184000.0 in 2023, then dropped by 4.35% to $176000.0 in 2024, then tumbled by 51.7% to $85000.0 in 2025, then soared by 491.68% to $502932.0 in 2026.
• The last three Share-based Compensation figures came in at $502932.0 (Q2 2026), $505010.0 (Q1 2026), and $85000.0 (Q4 2025), per Business Quant data.